动静脉内瘘动脉瘤修补术与通畅性改善及透析通路废弃减少相关
该回顾性研究纳入2016至2021年单家医院系统内303例因动脉瘤性动静脉内瘘接受手术的患者,比较动脉瘤修补术(123例)与间置移植物(180例)。多变量Cox回归显示间置移植物与2年时初级辅助通畅、次级通畅丢失及透析通路废弃风险升高相关。作者建议在动静脉内瘘动脉瘤需要修复时使用动脉瘤修补术,但需考虑患者合并症、解剖、剩余通路选项和偏好。
要点
- 间置移植物与2年初级辅助通畅丢失风险升高相关(aHR 2.42,95%CI 1.18-4.95)。
- 间置移植物与2年次级通畅丢失风险升高相关(aHR 3.10,95%CI 1.21-7.94)。
- 间置移植物与2年透析通路废弃风险升高相关(aHR 3.07,95%CI 1.61-5.87)。
核心结论
- 动静脉内瘘动脉瘤修补术与初级辅助通畅和次级通畅改善及透析通路废弃减少相关。
- 作者建议在动静脉内瘘动脉瘤需要修复时使用动脉瘤修补术,但制定手术方案时应考虑患者合并症、动静脉内瘘解剖、剩余透析通路选项和患者偏好。
研究设计与样本
- 回顾性综述,使用现行 procedural terminology 编码在单家医院系统内筛选2016至2021年间因动脉瘤性动静脉内瘘接受手术治疗的患者,经手术报告复核后纳入。
- 共381例(2.4%)手术与动脉瘤性动静脉内瘘手术治疗相关,排除58例原发性动静脉内瘘结扎和20例其他类型修复,最终303例纳入分析。
- 按手术方式分为动脉瘤修补术组(n=123;41%)和间置移植物组(n=180;59%)。
- 主要结局为初级辅助通畅和次级通畅,次要结局为透析通路废弃;采用多变量Cox比例风险回归检验修复方式与结局的关联。
- 中位随访11.1个月(四分位距3.6-25.2个月)。
主要发现
- 动脉瘤修补术组与间置移植物组在男性(68% vs 63%)、高血压(98% vs 98%)和中心静脉狭窄(14% vs 22%)方面无差异。
- 动脉瘤修补术组患者较间置移植物组更年轻(中位年龄54岁 vs 59岁),糖尿病(41% vs 59%)、冠心病(41% vs 58%)和充血性心力衰竭(41% vs 55%)比例更低,上臂通路比例更低(72% vs 92%)。
- 两组30天伤口并发症(1% vs 3%)和手术部位感染(4% vs 6%)发生率无差异。
- 多变量Cox回归显示,间置移植物与2年时初级辅助通畅丢失相关(aHR 2.42;95%CI 1.18-4.95)。
- 间置移植物与2年时次级通畅丢失相关(aHR 3.10;95%CI 1.21-7.94),并与2年时透析通路废弃相关(aHR 3.07;95%CI 1.61-5.87;P < .05 for all)。
临床怎么用
- 作者建议在动静脉内瘘动脉瘤需要修复时使用动脉瘤修补术。
- 作者指出制定手术方案时应考虑患者合并症、动静脉内瘘解剖、剩余透析通路选项和患者偏好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Upper extremity hemodialysis arteriovenous fistulas (AVFs) can become aneurysmal over time due to repeated cannulation and/or outflow steno-occlusive disease. The optimal surgical management of aneurysmal AVFs (aneurysmorrhaphy vs interposition graft) has remained unclear. METHODS: We performed a retrospective review in which current procedural terminology codes were used to screen for patients who had undergone surgical treatment of aneurysmal AVFs between 2016 and 2021 at a single hospital system. The patients were included after a review of the operative reports. The cases were divided by surgical procedure (aneurysmorrhaphy vs interposition graft placement). The patients who had undergone primary AVF ligation or other types of repair were excluded. The primary outcomes were primary assisted and secondary patency, and the secondary outcome was dialysis access abandonment. Multivariable Cox proportional hazards regression was used to test the association between the type of AVF aneurysm repair and the primary and secondary outcomes. RESULTS: From 2016 to 2021, 6951 patients had undergone 16,190 dialysis access procedures. Of these procedures, 381 (2.4%) were related to surgical treatment of an aneurysmal AVF. We excluded 58 primary AVF ligation cases and 20 cases involving other types of repair, leaving 303 cases for analysis. These were divided into two groups: aneurysmorrhaphy (n = 123; 41%) and interposition graft (n = 180; 59%). No differences were found between the groups in male gender (68% vs 63%), hypertension (98% vs 98%), or central stenosis (14% vs 22%). The patients who had undergone aneurysmorrhaphy were younger (median age, 54 years vs 59 years); had had a lower rate of diabetes (41% vs 59%), coronary artery disease (41% vs 58%), and congestive heart failure (41% vs 55%); and were less likely to have undergone upper arm access (72% vs 92%). The median follow-up was 11.1 months (interquartile range, 3.6-25.2 months). No differences were found in the incidence of 30-day wound complications (1% vs 3%) or surgical site infections (4% vs 6%). On multivariable Cox regression, interposition graft placement was associated with the loss of primary assisted patency (adjusted hazard ratio [aHR], 2.42; 95% confidence interval [CI], 1.18-4.95), loss of secondary patency (aHR, 3.10; 95% CI, 1.21-7.94), and abandonment of dialysis access (aHR, 3.07; 95% CI, 1.61-5.87; P < .05 for all) at 2 years. CONCLUSIONS: AVF aneurysmorrhaphy was associated with improved primary assisted and secondary patency and decreased abandonment of dialysis access. We suggest using aneurysmorrhaphy when AVF aneurysms are indicated for repair. However, individual factors such as patient comorbidities, AVF anatomy, remaining dialysis access options, and patient preference should be considered when planning the surgical approach.
引用
- Chang R, Alabi O, Mahajan A, et al. Arteriovenous fistula aneurysmorrhaphy is associated with improved patency and decreased vascular access abandonment. J Vasc Surg. 2022. PMID: 36368647. doi:10.1016/j.jvs.2022.10.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。